Merck 0731 update

Prescription Medicine News. Vaccine News. Show more. Reset Search. Items per page 10 25 50 Related links.

Company statements Read our latest company statements. Media library Access videos, logos, photos, infographics and media contacts. About our company Discover how we invent for life. Decline Accept. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. Search for terms. Save this study. Warning You have reached the maximum number of saved studies Listing a study does not mean it has been evaluated by the U.

Federal Government. Read our disclaimer for details. Last Update Posted : January 30, Study Description. Arms and Interventions. Outcome Measures. Eligibility Criteria. Information from the National Library of Medicine Choosing to participate in a study is an important personal decision.

Inclusion Criteria: Patients who are at least 18 years of age with recurrent or non-responsive solid tumors, or cancers for whom standard therapy does not exist. Part of the study includes only patients who have taxane-resistant cancers. Exclusion Criteria: Patients who have had treatment with any investigational therapy within the past 30 days. Discover more. Our areas of focus We focus on scientific innovation to deliver medicines and vaccines that may help millions of people around the world.

Oncology Our mission is to deliver innovations that extend and improve the lives of people with cancer. Infectious diseases. Infectious diseases We play an important role in discovering and developing innovative medicines and vaccines to treat and prevent infectious diseases, including HIV and Ebola.

Cardio-metabolic disorders. Cardio-metabolic disorders We are determined to find solutions for the most serious chronic health challenges, such as cardiovascular disease and diabetes. Calling all inventors Are you passionate about building a meaningful career? Join our team. Corporate responsibility. About our responsibility. Investor relations. Visit investor relations. Decline Accept. You are leaving Merck. Cancel Continue. Welcome to Merck.